S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:BMEA

Biomea Fusion (BMEA) Stock Forecast, Price & News

$38.24
+0.70 (+1.86%)
(As of 06/6/2023 ET)
Compare
Today's Range
$37.54
$39.17
50-Day Range
$23.98
$38.24
52-Week Range
$5.30
$39.17
Volume
1.14 million shs
Average Volume
622,199 shs
Market Capitalization
$1.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.29

Biomea Fusion MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.3% Upside
$40.29 Price Target
Short Interest
Bearish
19.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.04mentions of Biomea Fusion in the last 14 days
Based on 5 Articles This Week
Insider Trading
Balanced
Insiders Both Buying and Selling
Proj. Earnings Growth
Decreasing
From ($3.54) to ($3.72) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.44 out of 5 stars

Medical Sector

911th out of 981 stocks

Pharmaceutical Preparations Industry

430th out of 460 stocks


BMEA stock logo

About Biomea Fusion (NASDAQ:BMEA) Stock

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Receive BMEA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomea Fusion and its competitors with MarketBeat's FREE daily newsletter.

BMEA Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Biomea Fusion (NASDAQ: BMEA)
Biomea: Novel Approach To Diabetes And Cancer
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
Biomea Fusion (NASDAQ:BMEA) Coverage Initiated at Barclays
Recap: Biomea Fusion Q1 Earnings
BMEA Biomea Fusion, Inc.
See More Headlines

BMEA Price History

BMEA Company Calendar

Last Earnings
3/28/2023
Today
6/06/2023
Next Earnings (Estimated)
8/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BMEA
Fax
N/A
Employees
51
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.29
High Stock Price Forecast
$53.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+6.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-81,830,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.69 per share

Miscellaneous

Free Float
26,100,000
Market Cap
$1.35 billion
Optionable
Not Optionable
Beta
-1.04

Key Executives

  • Mr. Thomas Andrew Butler (Age 41)
    Co-Founder, Chairman & CEO
    Comp: $772.86k
  • Mr. Ramses M. ErdtmannMr. Ramses M. Erdtmann (Age 59)
    Co-Founder, Pres, COO & Director
    Comp: $570.57k
  • Mr. Franco ValleMr. Franco Valle (Age 41)
    CFO & Principal Accounting Officer
    Comp: $251.69k
  • Mr. Heow Tan (Age 63)
    Chief Technology & Quality Officer
  • Ms. Naomi Cretcher
    Chief People Officer
  • Dr. Thorsten Kirschberg Ph.D. (Age 52)
    Exec. VP of Chemistry
  • Dr. Stephan Morris M.D.
    Chief Medical Officer
  • Mr. Ravi Upasani
    Sr. VP of Intellectual Property













BMEA Stock - Frequently Asked Questions

Should I buy or sell Biomea Fusion stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Biomea Fusion in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BMEA shares.
View BMEA analyst ratings
or view top-rated stocks.

What is Biomea Fusion's stock price forecast for 2023?

7 equities research analysts have issued twelve-month price objectives for Biomea Fusion's stock. Their BMEA share price forecasts range from $22.00 to $53.00. On average, they predict the company's stock price to reach $40.29 in the next twelve months. This suggests a possible upside of 6.0% from the stock's current price.
View analysts price targets for BMEA
or view top-rated stocks among Wall Street analysts.

How have BMEA shares performed in 2023?

Biomea Fusion's stock was trading at $8.43 at the beginning of 2023. Since then, BMEA shares have increased by 350.8% and is now trading at $38.00.
View the best growth stocks for 2023 here
.

When is Biomea Fusion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our BMEA earnings forecast
.

How were Biomea Fusion's earnings last quarter?

Biomea Fusion, Inc. (NASDAQ:BMEA) issued its earnings results on Tuesday, March, 28th. The company reported ($0.86) earnings per share for the quarter, missing analysts' consensus estimates of ($0.81) by $0.05.

What ETFs hold Biomea Fusion's stock?

ETFs with the largest weight of Biomea Fusion (NASDAQ:BMEA) stock in their portfolio include BlackRock Future Health ETF (BMED), Invesco Nasdaq Biotechnology ETF (IBBQ), iShares Biotechnology ETF (IBB), ProShares Ultra Nasdaq Biotechnology (BIB),

When did Biomea Fusion IPO?

(BMEA) raised $120 million in an initial public offering (IPO) on Friday, April 16th 2021. The company issued 7,500,000 shares at $15.00-$17.00 per share. J.P. Morgan, Jefferies and Piper Sandler served as the underwriters for the IPO.

What is Biomea Fusion's stock symbol?

Biomea Fusion trades on the NASDAQ under the ticker symbol "BMEA."

Who are Biomea Fusion's major shareholders?

Biomea Fusion's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (7.57%), Baker BROS. Advisors LP (5.97%), BlackRock Inc. (2.78%), Perceptive Advisors LLC (0.92%), Geode Capital Management LLC (0.60%) and JPMorgan Chase & Co. (0.47%). Insiders that own company stock include A2a Pharmaceuticals, Inc, Bihua Chen, Franco Valle, Global Healthcare Ma Cormorant, Michael JM Hitchcock and Rainer M Erdtmann.
View institutional ownership trends
.

How do I buy shares of Biomea Fusion?

Shares of BMEA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biomea Fusion's stock price today?

One share of BMEA stock can currently be purchased for approximately $38.00.

How much money does Biomea Fusion make?

Biomea Fusion (NASDAQ:BMEA) has a market capitalization of $1.35 billion. The company earns $-81,830,000.00 in net income (profit) each year or ($3.21) on an earnings per share basis.

How can I contact Biomea Fusion?

The official website for the company is www.biomeafusion.com. The company can be reached via phone at 650-980-9099 or via email at vsandwick@biomeafusion.com.

This page (NASDAQ:BMEA) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -